News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
284 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (139)
2 (2)
3 (2)
4 (263)
5 (284)
6 (276)
7 (405)
8 (162)
9 (3)
10 (5)
11 (319)
12 (292)
13 (259)
14 (347)
15 (194)
16 (3)
18 (231)
19 (227)
20 (215)
21 (270)
22 (125)
23 (3)
24 (1)
25 (36)
26 (319)
27 (300)
28 (276)
29 (278)
30 (5)
31 (14)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Total product and royalty revenues of $569 million (+24% vs Q1 2019) for the quarter ended March 31, 2020; Jakafi® (ruxolitinib) revenues of $459 million in Q1 2020 (+22% vs Q1 2019)
May 5, 2020
·
23 min read
BioMidwest
Exicure to Present AST-008 Updates at 2020 AACR Virtual Annual Meeting
Exicure, Inc., the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid constructs, will present at the American Association of Cancer Research Virtual Annual Meeting II, occurring June 22 – 24, 2020.
May 5, 2020
·
2 min read
Drug Development
Vifor Pharma Announces Akebia’s Positive Top-Line Results From Global Phase-III Program of vadadustat for Treatment of Anaemia Due to Chronic Kidney Disease in Adult Dialysis-Dependent Patients
Akebia’s vadadustat, an investigational oral HIF-PHI, achieves primary efficacy and cardiovascular safety endpoints
May 5, 2020
·
4 min read
Business
Roswell Biotechnologies and Imec to Develop First Molecular Electronics Biosensor Chips for Infectious Disease Surveillance, Precision Medicine and DNA Storage
Roswell Biotechnologies, Inc., the leader in molecular electronics sensor chips, and imec, a world-leading research and innovation hub in nanoelectronics and digital technologies, announced a partnership to develop the first commercially available molecular electronics biosensor chips.
May 5, 2020
·
5 min read
BioForest
InMed and Almac Group Developing Improved Cannabinoid Production Methods
InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol, announced that it is working with the Almac Group on a proprietary approach to augment current biosynthesis-based methods for cannabinoid production.
May 5, 2020
·
5 min read
Pharm Country
Oramed Pharmaceuticals to Present at the 80th American Diabetes Association Scientific Session, to be Held Virtually This Year in June
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced it will present during the 80 th American Diabe
May 5, 2020
·
4 min read
Business
Guardant Health and Patient Advocacy Groups Join Forces to Raise Awareness of the Importance of Complete Biomarker Testing for Patients with Metastatic Non-Small Cell Lung Cancer
Incomplete testing fails to meet current medical guideline standards, placing more than 80 percent1 of patients at increased risk of receiving a less effective treatment
May 5, 2020
·
8 min read
Pharm Country
AzurRx BioPharma Receives Approximately $721,000 for its 2019 CIR (French Research Tax Credit)
Received ~$2.52 million in aggregate CIR payments in 2020 CIR to be used to fund on-going MS1819 Phase 2 clinical studies in Europe
May 5, 2020
·
3 min read
Genetown
Psychemedics Announces a “Vaping Panel” to Detect and Deter the Use of Marijuana, CBD and NicotineA New and Cost-Effective Tool to Combat the E-cigarette Epidemic Among Youth
Psychemedics Corporation (NASDAQ: PMD ), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced a Vaping Panel to detect the use of Marijuana, CBD and Nicotine. This test provides a way for schools and businesses to detect the ingestion of these drugs by all methods including electronic cigarettes or smoking. Hair testing provides several significant advantages over other methods of testing including a 90
May 5, 2020
·
4 min read
FDA
Galderma Receives FDA Approval For Restylane® Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane ® Kysse for lip augmentation and the correction of upper perioral rhytids (wrinkles around upper lips) in adults over the age of 21.
May 5, 2020
·
7 min read
Previous
16 of 29
Next